Evidence map›Paper›PMID 36813178›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2023

Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients.

Mattison J Flakus, Sean P Kent, Eric M Wallat, Antonia E Wuschner, Erica Tennant, Poonam Yadav, Adam Burr, Menggang Yu, Gary E Christensen, Joseph M Reinhardt and 2 more

Open access · greenAbstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Research progress on predicting radiation pneumonia based on four-dimensional computed tomography ventilation imaging in lung cancer radiotherapy].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. COPD and Immune Checkpoint Inhibitors for Cancer: A Literature Review.International journal of chronic obstructive pulmonary disease · 2024
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Mattison J FlakusDepartment of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Sean P KentDepartment of Statistics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Eric M WallatDepartment of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Antonia E WuschnerDepartment of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Erica TennantUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Poonam YadavDepartment of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Adam BurrDepartment of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.
Menggang YuDepartment of Biostatistics and Medical Informatics, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.
Gary E ChristensenDepartment of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, USA.
Joseph M ReinhardtRoy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, USA.
John E BayouthDepartment of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Andrew M BaschnagelDepartment of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA. Electronic address: baschnagel@humonc.wisc.edu.
University of Wisconsin–Madison · USUW Health University Hospital · USUniversity of Iowa · USNorthwestern University · USOregon Health & Science University · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Predicting Pulmonary Function Change to Improve Radiation Planning and OutcomeR01CA166703 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BAYOUTH, JOHN · 2013 to 2017
$1.9M
NCI NIH HHS P30 CA014520NCI NIH HHS P30 CA086862NCI NIH HHS R01 CA166703
6 · The paper itself

Abstract

purposeTo identify metrics of radiation dose delivered to highly ventilated lung that are predictive of radiation-induced pneumonitis. METHODS AND MATERIALS: A cohort of 90 patients with locally advanced non-small cell lung cancer treated with standard fractionated radiation therapy (RT) (60-66 Gy in 30-33 fractions) were evaluated. Regional lung ventilation was determined from pre-RT 4-dimensional computed tomography (4DCT) using the Jacobian determinant of a B-spline deformable image registration to estimate lung tissue expansion during respiration. Multiple voxel-wise population- and individual-based thresholds for defining high functioning lung were considered. Mean dose and volumes receiving dose ≥ 5-60 Gy were analyzed for both total lung-ITV (MLD,V5-V60) and highly ventilated functional lung-ITV (fMLD,fV5-fV60). The primary endpoint was symptomatic grade 2+ (G2+) pneumonitis. Receiver operator curve (ROC) analyses were used to identify predictors of pneumonitis.

resultsG2+ pneumonitis occurred in 22.2% of patients, with no differences between stage, smoking status, COPD, or chemo/immunotherapy use between G<2 and G2+ patients (P≥ 0.18). Highly ventilated lung was defined as voxels exceeding the population-wide median of 18% voxel-level expansion. All total and functional metrics were significantly different between patients with and without pneumonitis (P≤ 0.039). Optimal ROC points predicting pneumonitis from functional lung dose were fMLD ≤ 12.3 Gy, fV5 ≤ 54% and fV20 ≤ 19 %. Patients with fMLD ≤ 12.3 Gy had a 14% risk of developing G2+ pneumonitis whereas risk significantly increased to 35% for those with fMLD > 12.3 Gy (P = 0.035).

conclusionsDose to highly ventilated lung is associated with symptomatic pneumonitis and treatment planning strategies should focus on limiting dose to functional regions. These findings provide important metrics to be used in functional lung avoidance RT planning and designing clinical trials.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiation PneumonitisHumansLungRespiration4D-CTFunctional lung avoidanceLung cancerPneumonitisVentilating lung

Identifiers

PMID36813178
PMCPMC10283046
OpenAlexW4321368621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.